focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNatwest Regulatory News (NWG)

Share Price Information for Natwest (NWG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 321.00
Bid: 320.00
Ask: 320.20
Change: -5.40 (-1.65%)
Spread: 0.20 (0.062%)
Open: 326.00
High: 327.40
Low: 319.90
Prev. Close: 326.40
NWG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Cash Tender Offer

4 Apr 2023 14:11

RNS Number : 3612V
NatWest Group plc
04 April 2023
 

 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON RESIDENT AND/OR LOCATED IN, ANY JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION IS UNLAWFUL (SEE "OFFER RESTRICTIONS" BELOW).

 

THIS ANNOUNCEMENT IS FOR INFORMATION ONLY AND IS NOT AN OFFER TO PURCHASE OR A SOLICITATION OF AN OFFER TO SELL ANY SECURITIES.

 

,

 

 

April 4, 2023

 

NATWEST GROUP PLC - RESULTS OF THE CASH TENDER OFFER FOR ANY AND ALL OF ITS OUTSTANDING 5.125% SUBORDINATED TIER 2 NOTES DUE 2024

NatWest Group plc (the "Offeror") is announcing today the results of its previously announced cash tender offer (the "Offer") for any and all of its outstanding 5.125% Subordinated Tier 2 Notes due 2024 (the "Notes").

The Offer was made on the terms and subject to the conditions set out in the offer to purchase dated March 27, 2023 and the related Notice of Guaranteed Delivery (the "Offer to Purchase"). Capitalized terms not otherwise defined in this announcement have the same meaning as in the Offer to Purchase.

Results of the Offer

The Tender Agent informed the Offeror that $339,732,000 in aggregate principal amount of the Notes were validly tendered and not validly withdrawn by 5:00 p.m., New York City time, on April 3, 2023 (the "Expiration Deadline"), as more fully set forth in the table below. The Offeror has accepted all Notes that were validly tendered and not validly withdrawn prior to the Expiration Deadline. As of the Expiration Deadline, no Notes were tendered using the Guaranteed Delivery Procedures.

The Offeror estimates that the impact on its Q2 2023 results will be de minimis.

With respect to the Offer, the table below sets forth, among other things, the principal amount of Notes validly tendered and not validly withdrawn at or prior to the Expiration Deadline:

Title of Security

Issuer(1)

ISIN/CUSIP

Principal Amount Outstanding

Aggregate Principal Amount Tendered Excluding Notes Tendered Using Guaranteed Delivery Procedures

Purchase Price(2)

5.125% Subordinated Tier 2 Notes due 2024

The Royal Bank of Scotland Group plc(1)

US780099CH81 /

780099CH8

$876,108,000

$339,732,000

$996.76

 

(1) Now NatWest Group plc.

(2) Per $1,000 principal amount of the Notes validly tendered and accepted for purchase.

 

The Settlement Date is expected to be April 5, 2023 and the Guaranteed Delivery Settlement Date is expected to be April 6, 2023. For the avoidance of doubt, Holders whose Notes are tendered and purchased pursuant to the Guaranteed Delivery Procedures will not receive payment in respect of any interest or any distribution, as the case may be, for the period from and including the Settlement Date to the Guaranteed Delivery Settlement Date.

 

FURTHER INFORMATION

 

Kroll Issuer Services Limited acted as tender agent with respect to the Offer. NatWest Markets Securities Inc., an affiliate of the Offeror, acted as Global Arranger and Lead Dealer Manager with respect to the Offer. TD Securities (USA) LLC (together with NatWest Markets Securities Inc.) acted as Dealer Manager with respect to the Offer.

 

Questions regarding the Offer should be directed to NatWest Markets Securities Inc. at +44 20 7678 5222 (UK), +1 203 897 6166 (U.S.) or +1 866 884 2071 (U.S. Toll Free) and TD Securities (USA) LLC at +1 212 827 2842 (U.S.) or +1 866 584 2096 (U.S. Toll Free).

 

FORWARD-LOOKING STATEMENTS

 

From time to time, the Offeror may make statements, both written and oral, regarding its assumptions, projections, expectations, intentions or beliefs about future events. These statements constitute "forward-looking statements". The Offeror cautions that these statements may and often do vary materially from actual results. Accordingly, the Offeror cannot assure you that actual results will not differ materially from those expressed or implied by the forward-looking statements. You should read the sections entitled "Risk Factors" in the Offer to Purchase and in the Annual Report of the Offeror on Form 20-F, which is incorporated by reference therein, and in the section entitled "Forward-Looking Statements" in the Annual Report of the Offeror on Form 20-F, which is incorporated by reference in the Offer to Purchase.

 

Any forward-looking statements made herein, the Offer to Purchase or in the documents incorporated by reference therein speak only as of the date they are made. Except as required by the U.K. Financial Conduct Authority, any applicable stock exchange or any applicable law, the Offeror expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement contained herein, in the Offer to Purchase or the documents incorporated by reference therein to reflect any changes in expectations with regard thereto or any new information or any changes in events, conditions or circumstances on which any such statement is based. The reader should, however, consult any additional disclosures that the Offeror has made or may make in documents that the Offeror has filed or may file with the U.S. Securities and Exchange Commission.

 

 

Legal Entity Identifier

NatWest Group plc

2138005O9XJIJN4JPN90

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTEXZLFBXZLFBBB
Date   Source Headline
22nd Mar 20245:47 pmRNSTransaction in Own Shares
22nd Mar 20249:30 amRNSDirector Declaration
21st Mar 20245:49 pmRNSTransaction in Own Shares
20th Mar 20245:46 pmRNSTransaction in Own Shares
19th Mar 20245:47 pmRNSTransaction in Own Shares
19th Mar 20249:01 amRNSHoldings in Company
18th Mar 20245:45 pmRNSTransaction in Own Shares
18th Mar 20244:00 pmRNSNotice of AGM
18th Mar 202412:00 pmRNSDirector/PDMR Shareholding
15th Mar 20245:32 pmRNSTransaction in Own Shares
15th Mar 202410:19 amRNSHolding(s) in Company - HMT shareholding
14th Mar 20245:48 pmRNSTransaction in Own Shares
13th Mar 20245:13 pmRNSTransaction in Own Shares
12th Mar 20245:08 pmRNSTransaction in Own Shares
11th Mar 20245:39 pmRNSTransaction in Own Shares
8th Mar 20245:14 pmRNSTransaction in Own Shares
8th Mar 20242:15 pmRNSDirector/PDMR Shareholding
8th Mar 202412:41 pmRNSHolding(s) in Company
7th Mar 20245:26 pmRNSTransaction in Own Shares
7th Mar 202412:13 pmRNSNotice of Redemption
6th Mar 20245:23 pmRNSTransaction in Own Shares
6th Mar 20249:37 amRNSHolding(s) in Company - HMT Shareholding
5th Mar 20245:48 pmRNSTransaction in Own Shares
4th Mar 20245:49 pmRNSTransaction in Own Shares
1st Mar 20245:29 pmRNSTransaction in Own Shares
29th Feb 20245:28 pmRNSTransaction in Own Shares
29th Feb 20242:49 pmRNSTotal Voting Rights
29th Feb 202412:36 pmRNSNatWest Group plc Filing of Registration Statement
28th Feb 20245:12 pmRNSTransaction in Own Shares
27th Feb 20245:11 pmRNSTransaction in Own Shares
27th Feb 202411:04 amRNSNatWest Group plc Filing of Registration Statement
26th Feb 20245:25 pmRNSTransaction in Own Shares
26th Feb 202410:11 amRNSHolding(s) in Company – HMT shareholding
26th Feb 20247:00 amRNSFiling of Annual Report on Form 20-F with US SEC
23rd Feb 20245:20 pmRNSTransaction in Own Shares
22nd Feb 20245:15 pmRNSTransaction in Own Shares
22nd Feb 202411:01 amRNSNotice of Redemption
21st Feb 20245:24 pmRNSTransaction in Own Shares
20th Feb 20245:49 pmRNSTransaction in Own Shares
19th Feb 202412:03 pmRNSHolding(s) in Company
19th Feb 20249:09 amRNSCommencement of On Market Share Buyback Programme
16th Feb 20241:28 pmRNSPublication of Supplementary Prospectus
16th Feb 20247:01 amRNSAnnual Financial Report - NWM NV
16th Feb 20247:01 amRNSAnnual Financial Report - NWG plc
16th Feb 20247:01 amRNSFinal Results - NWG plc
16th Feb 20247:00 amRNSPaul Thwaite appointed as NatWest Group CEO
14th Feb 20244:58 pmRNSTransaction in Own Shares
13th Feb 20245:23 pmRNSTransaction in Own Shares
9th Feb 20245:29 pmRNSTransaction in Own Shares
8th Feb 20245:35 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.